PALI
Income statement / Annual
Last year (2024), Palisade Bio, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Palisade Bio, Inc.'s net income was -$14.44 M.
See Palisade Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$250,000.00 |
$0.00 |
$0.00 |
$13,520.00 |
$15,394.00 |
$260,000.00 |
$260,000.00 |
$16,246.00 |
$10,417.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$167,000.00
|
$168,000.00
|
$146,000.00
|
$0.00
|
-$990,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$250,000.00
|
-$167,000.00
|
-$168,000.00
|
-$132,480.00
|
$15,394.00
|
$1.25 M
|
$260,000.00
|
$16,246.00
|
$10,417.00
|
| Gross Profit Ratio |
0
|
1
|
0
|
0
|
-9.8
|
1
|
4.81
|
1
|
1
|
1
|
| Research and Development Expenses |
$9.06 M
|
$6.89 M
|
$6.55 M
|
$32.55 M
|
$3.10 M
|
$4.06 M
|
$3.96 M
|
$8.00 M
|
$12.84 M
|
$12.64 M
|
| General & Administrative Expenses |
$5.80 M
|
$6.20 M
|
$8.76 M
|
$9.31 M
|
$6.20 M
|
$7.27 M
|
$3.57 M
|
$5.47 M
|
$7.50 M
|
$6.53 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$2.83 M
|
$807,462.00
|
-$289,208.00
|
-$495,508.00
|
-$345,460.00
|
| Selling, General & Administrative Expenses |
$5.80 M
|
$6.20 M
|
$8.76 M
|
$9.31 M
|
$6.20 M
|
$4.44 M
|
$4.37 M
|
$5.18 M
|
$7.00 M
|
$6.18 M
|
| Other Expenses |
$0.00
|
$225,000.00
|
$158,000.00
|
-$1.74 M
|
$13,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$14.86 M
|
$13.32 M
|
$15.31 M
|
$41.85 M
|
$9.30 M
|
$8.50 M
|
$8.33 M
|
$13.19 M
|
$19.85 M
|
$18.82 M
|
| Cost And Expenses |
$0.00
|
$13.32 M
|
$15.31 M
|
$41.85 M
|
$9.30 M
|
$8.65 M
|
$8.52 M
|
$13.48 M
|
$20.18 M
|
$19.17 M
|
| Interest Income |
$0.00
|
$0.00
|
$13,000.00
|
$3.08 M
|
$33,532.00
|
$67,731.00
|
$78,780.00
|
$70,269.00
|
$58,835.00
|
$69,549.00
|
| Interest Expense |
$0.00
|
$15,000.00
|
$13,000.00
|
$2.40 M
|
$235,000.00
|
$8,920.00
|
$7,698.00
|
$159,066.00
|
$1.14 M
|
$1.82 M
|
| Depreciation & Amortization |
-$409,000.00
|
$4,000.00
|
$167,000.00
|
$168,000.00
|
$146,000.00
|
$143,859.00
|
$185,803.00
|
$289,208.00
|
$337,508.00
|
$345,460.00
|
| EBITDA |
-$14.86 M |
-$12.28 M |
-$15.31 M |
-$24.05 M |
-$9.94 M |
-$8.20 M |
-$4.73 M |
-$15.22 M |
-$19.60 M |
-$18.74 M |
| EBITDA Ratio |
0
|
-49.12
|
0
|
0
|
-735.28
|
-532.6
|
-18.2
|
-58.53
|
-1206.19
|
-1799.2
|
| Operating Income Ratio |
0
|
-52.28
|
0
|
0
|
-687.65
|
-560.72
|
-31.77
|
-50.83
|
-1241.34
|
-1838.97
|
| Total Other Income/Expenses Net |
$421,000.00
|
$770,000.00
|
$1.46 M
|
$15.24 M
|
-$1.03 M
|
$280,043.00
|
-$1.86 M
|
-$2.45 M
|
-$907,768.00
|
-$1.75 M
|
| Income Before Tax |
-$14.44 M
|
-$12.30 M
|
-$14.26 M
|
-$26.62 M
|
-$10.32 M
|
-$8.35 M
|
-$4.92 M
|
-$15.67 M
|
-$21.07 M
|
-$20.90 M
|
| Income Before Tax Ratio |
0
|
-49.2
|
0
|
0
|
-763.46
|
-542.53
|
-18.94
|
-60.25
|
-1297.22
|
-2006.71
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$1.46 M
|
$655,000.00
|
$248,000.00
|
$288,963.00
|
$3.34 M
|
-$2.20 M
|
$703,529.00
|
$68,833.00
|
| Net Income |
-$14.44 M
|
-$12.30 M
|
-$12.80 M
|
-$27.27 M
|
-$10.57 M
|
-$8.35 M
|
-$4.92 M
|
-$15.67 M
|
-$21.07 M
|
-$20.90 M
|
| Net Income Ratio |
0
|
-49.2
|
0
|
0
|
-781.8
|
-542.53
|
-18.94
|
-60.25
|
-1297.22
|
-2006.71
|
| EPS |
-2.48 |
-1.8 |
-14.54 |
-173.93 |
-12.7 |
-14.78 |
-18.02 |
-71.59 |
-126.11 |
-197.36 |
| EPS Diluted |
-1.69 |
-1.8 |
-14.54 |
-145.87 |
-44.53 |
-35.18 |
-18.02 |
-71.34 |
-126.11 |
-197.36 |
| Weighted Average Shares Out |
$5.82 M
|
$6.84 M
|
$880,095.00
|
$156,795.00
|
$832,305.00
|
$565,215.00
|
$273,240.00
|
$218,835.00
|
$167,115.00
|
$105,915.00
|
| Weighted Average Shares Out Diluted |
$8.54 M
|
$6.84 M
|
$880,305.00
|
$186,960.00
|
$237,390.00
|
$237,390.00
|
$273,240.00
|
$219,600.00
|
$167,115.00
|
$105,915.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
